Erschienen: 14.05.2020 Abbildung von Rahbari / Niewaal | Biomarkers in Drug Discovery and Development | 2. Auflage | 2020 |

Rahbari / Niewaal / Bleavins

Biomarkers in Drug Discovery and Development

A Handbook of Practice, Application, and Strategy

lieferbar (3-5 Tage)

Buch. Hardcover

2. Auflage. 2020

In englischer Sprache

Wiley John + Sons. ISBN 978-1-119-18750-9

Format (B x L): 15.6 x 23.6 cm

Gewicht: 859 g


This book continues the legacy of a well-established reference within the pharmaceutical industry - providing perspective, covering recent developments in technologies that have enabled the expanded use of biomarkers, and discussing biomarker characterization and validation and applications throughout drug discovery and development. * Explains where proper use of biomarkers can substantively impact drug development timelines and costs, enable selection of better compounds and reduce late stage attrition, and facilitate personalized medicine * Helps readers get a better understanding of biomarkers and how to use them, for example which are accepted by regulators and which still non-validated and exploratory * Updates developments in genomic sequencing, and application of large data sets into pre-clinical and clinical testing; and adds new material on data mining, economics, and decision making, personal genetic tools, and wearable monitoring * Includes case studies of biomarkers that have helped and hindered decision making * Reviews of the first edition: "If you are interested in biomarkers, and it is difficult to imagine anyone reading this who wouldn't be, then this book is for you." (ISSX) and "...provides a good introduction for those new to the area, and yet it can also serve as a detailed reference manual for those practically involved in biomarker implementation." (ChemMedChem)

Top-Produkte dieser Kategorie


  • Rezensionen

    Dieses Set enthält folgende Produkte:
      Auch in folgendem Set erhältlich:
      • nach oben

        Ihre Daten werden geladen ...